A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Condition(s) studied
Investigational drug(s) / intervention(s)
Brenipatide: Administered SC
Placebo: Administered SC
Study summary
This study evaluates the efficacy and safety of brenipatide when compared to placebo for reducing the risk of relapse to cigarette smoking in adults who have recently quit.
Study participation will last approximately 34 weeks with up to 17 study visits, which includes a 2-week screening period, 24-week treatment period, 8-week safety follow-up period.
Eligibility
Primary outcome measure(s)
- Percentage of Participants that Achieve Carbon Monoxide (CO)-Confirmed Continuous Abstinence from Cigarette Smoking with Allowed Slips — Week 1 to Week 24
Trial sites (29)
| Facility | City | Region | Status |
|---|---|---|---|
| Woodland Research Northwest | Rogers | Arkansas | Recruiting |
| Hillcrest Medical Research | DeLand | Florida | Completed |
| TecTum Research | Hollywood | Florida | Recruiting |
| K2 Medical Research ORLANDO | Maitland | Florida | Recruiting |
| GTL Medical & Research Group | Miami | Florida | Recruiting |
| Conquest Research - Orlando | Orlando | Florida | Recruiting |
| North Georgia Clinical Research | Woodstock | Georgia | Recruiting |
| Revival Research Institute, LLC | Dearborn | Michigan | Recruiting |
| Arch Clinical Trials | St Louis | Missouri | Recruiting |
| Vector Clinical Trials | Las Vegas | Nevada | Recruiting |
| Rochester Clinical Research, LLC | Rochester | New York | Recruiting |
| Coastal Carolina Research Center | North Charleston | South Carolina | Recruiting |
| Circle Clinical Research | Sioux Falls | South Dakota | Recruiting |
| FutureSearch Trials of Dallas | Dallas | Texas | Recruiting |
| Adams Clinical Dallas | DeSoto | Texas | Recruiting |
| The University of Texas Health Science Center at Houston | Houston | Texas | Recruiting |
| Health Research of Hampton Roads, Inc. | Newport News | Virginia | Recruiting |
| Eastside Research Associates | Redmond | Washington | Recruiting |
| Beijing Chaoyang Hospital, Capital Medical University | Beijing | China | Recruiting |
| Beijing Anding Hospital - Affiliated Capital University of Medical Science | Beijing | China | Recruiting |
| Sichuan Provincial People's Hospital | Chengdu | China | Recruiting |
| 2nd Affiliated Hospital Chongqing Medical University | Chongqing | China | Recruiting |
| Sir Run Run Shaw Hospital of Zhejiang University School of Medicine | Hangzhou | China | Recruiting |
| Taizhou Hospital of Zhejiang Province | Linhai | China | Recruiting |
| The first affiliated hospital of Ningbo university | Ningbo | China | Recruiting |
| The University of Hong Kong-Shenzhen Hospital | Shenzhen | China | Recruiting |
| Miyazaki RC Clinic | Shinagawa-ku | Japan | Recruiting |
| Samoncho Clinic | Shinjuku | Japan | Recruiting |
| Higashi Shinjuku Clinic | Tokyo | Japan | Recruiting |
More Eli Lilly and Company trials in Japan
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07223840 on ClinicalTrials.gov ↗ ← All trials in Japan